A generative recommender system with GMM prior for cancer drug generation and sensitivity prediction

• URL: http://arxiv.org/abs/2206.03555v1
• Date: Tue, 7 Jun 2022 20:13:03 GMT
• Title: A generative recommender system with GMM prior for cancer drug generation and sensitivity prediction
• Authors: Krzysztof Koras, Marcin Mo\.zejko, Paulina Szymczak, Eike Staub, and Ewa Szczurek
• Abstract summary: We present VADEERS, a Variational Autoencoder-based Drug Efficacy Estimation Recommender System. The generation of compounds is performed by a novel variational autoencoder with a semi-supervised Gaussian Mixture Model (GMM) prior. VADEERS offers a comprehensive model of drugs and cell lines properties and relationships between them, as well as a guided generation of novel compounds.
• Score: 1.0128447823756244
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Recent emergence of high-throughput drug screening assays sparkled an intensive development of machine learning methods, including models for prediction of sensitivity of cancer cell lines to anti-cancer drugs, as well as methods for generation of potential drug candidates. However, a concept of generation of compounds with specific properties and simultaneous modeling of their efficacy against cancer cell lines has not been comprehensively explored. To address this need, we present VADEERS, a Variational Autoencoder-based Drug Efficacy Estimation Recommender System. The generation of compounds is performed by a novel variational autoencoder with a semi-supervised Gaussian Mixture Model (GMM) prior. The prior defines a clustering in the latent space, where the clusters are associated with specific drug properties. In addition, VADEERS is equipped with a cell line autoencoder and a sensitivity prediction network. The model combines data for SMILES string representations of anti-cancer drugs, their inhibition profiles against a panel of protein kinases, cell lines biological features and measurements of the sensitivity of the cell lines to the drugs. The evaluated variants of VADEERS achieve a high r=0.87 Pearson correlation between true and predicted drug sensitivity estimates. We train the GMM prior in such a way that the clusters in the latent space correspond to a pre-computed clustering of the drugs by their inhibitory profiles. We show that the learned latent representations and new generated data points accurately reflect the given clustering. In summary, VADEERS offers a comprehensive model of drugs and cell lines properties and relationships between them, as well as a guided generation of novel compounds.

Related papers

• Accelerating Drug Safety Assessment using Bidirectional-LSTM for SMILES Data [0.0]
  Bi-Directional Long Short Term Memory (BiLSTM) is a variant of Recurrent Neural Network (RNN) that processes input molecular sequences. The proposed work aims to understand the sequential patterns encoded in the SMILES strings, which are then utilised for predicting the toxicity of the molecules.
  arXiv  Detail & Related papers  (2024-07-08T18:12:11Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• drGAT: Attention-Guided Gene Assessment of Drug Response Utilizing a Drug-Cell-Gene Heterogeneous Network [9.637695046701493]
  drGAT is a graph deep learning model that can predict sensitivity to drugs. drGAT has superior performance over existing models, achieving 78% accuracy and 76% F1 score for 269 DNA-damaging compounds. Our method can be used to accurately predict sensitivity to drugs and may be useful in the identification of biomarkers relating to the treatment of cancer patients.
  arXiv  Detail & Related papers  (2024-05-14T22:16:52Z)
• Predicting Single-cell Drug Sensitivity by Adaptive Weighted Feature for Adversarial Multi-source Domain Adaptation [9.043161950476055]
  scAdaDrug is a multi-source adaptive weighting model to predict single-cell drug sensitivity. Our model achieved state-of-the-art performance in predicting drug sensitivity on sinle-cell datasets, as well as on cell line and patient datasets.
  arXiv  Detail & Related papers  (2024-03-08T12:31:03Z)
• Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization [0.7070726553564699]
  We propose the use of contrastive learning to improve learned drug and cell line representations. We find that our learned representations exhibit a more balances reliance on drug- and cell line-derived features when making predictions.
  arXiv  Detail & Related papers  (2023-10-20T04:18:47Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design [133.1268990638971]
  De novo drug design based on the structure of a target protein can provide novel drug candidates. We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
  arXiv  Detail & Related papers  (2022-08-30T09:32:39Z)
• MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy [2.446672595462589]
  We propose a multimodal graph neural network that can predict the synergistic effect of drug combinations for cancer treatment. Our model captures the representation based on the context of drugs at multiple scales based on a drug-protein interaction network and metadata. We demonstrate that the model makes high-quality predictions over a wide range of cancer cell line tissues.
  arXiv  Detail & Related papers  (2021-10-28T13:10:25Z)
• Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response [49.86828302591469]
  In this paper, we apply transfer learning to the prediction of anti-cancer drug response. We apply the classic transfer learning framework that trains a prediction model on the source dataset and refines it on the target dataset. The ensemble transfer learning pipeline is implemented using LightGBM and two deep neural network (DNN) models with different architectures.
  arXiv  Detail & Related papers  (2020-05-13T20:29:48Z)
• A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning [49.86828302591469]
  We train >35,000 neural network models, sweeping over common featurization techniques. We found the RNA-seq to be highly redundant and informative even with subsets larger than 128 features.
  arXiv  Detail & Related papers  (2020-04-30T20:42:17Z)
• Short Term Blood Glucose Prediction based on Continuous Glucose Monitoring Data [53.01543207478818]
  This study explores the use of Continuous Glucose Monitoring (CGM) data as input for digital decision support tools. We investigate how Recurrent Neural Networks (RNNs) can be used for Short Term Blood Glucose (STBG) prediction.
  arXiv  Detail & Related papers  (2020-02-06T16:39:44Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.